retatrutide clinical trials efficacy and safety of retatrutide, a GIP, GLP-1, and glucagon receptor agonist, in people with type 2 diabetes and inadequate glycaemic control with diet and exercise (TRANSCEND-T2D-1): a double-blind, randomised, phase 3 Retatrutide for weight loss: Study

Patients should also be aware of rare but serious risks including pancreatitis, gallbladder disease, and potential worsening of diabetic retinopathy, particularly with rapid improvement in glucose control

Consumers exiting GLP-1 therapies are looking for maintenance solutions to sustain their weight loss without medication

8 mg per week Produced significant reductions in body weight, making it a potential therapeutic sweet spot

hazard ratio 0.67, 0.32 to 1.41)

Known as the body's "master antioxidant," glutathione plays an essential role in protecting your cells from oxidative stress, supporting your liver's natural detoxification pathways, and helping your body recover from the demands of everyday life